UPLOAD Filing
Monopar Therapeutics
Date: July 25, 2025 · CIK: 0001645469 · Accession: 0000000000-25-007847
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-39070
Letter
Re: Monopar Therapeutics Inc. Form 10-K for Fiscal Year Ended December 31, 2024 File No. 001-39070 Dear Quan Vu:
July 25, 2025
Quan Vu Chief Financial Officer Monopar Therapeutics Inc. 1000 Skokie Blvd., Suite 350 Wilmette, IL 60091
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 25, 2025 Quan Vu Chief Financial Officer Monopar Therapeutics Inc. 1000 Skokie Blvd., Suite 350 Wilmette, IL 60091 Re: Monopar Therapeutics Inc. Form 10-K for Fiscal Year Ended December 31, 2024 File No. 001-39070 Dear Quan Vu: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>